TW200603806A - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
TW200603806A
TW200603806A TW094120115A TW94120115A TW200603806A TW 200603806 A TW200603806 A TW 200603806A TW 094120115 A TW094120115 A TW 094120115A TW 94120115 A TW94120115 A TW 94120115A TW 200603806 A TW200603806 A TW 200603806A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical compound
phenylglycinyl
piperidin
indole
piperazine
Prior art date
Application number
TW094120115A
Other languages
English (en)
Chinese (zh)
Inventor
Julie Kay Bush
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TW200603806A publication Critical patent/TW200603806A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW094120115A 2004-06-30 2005-06-17 Pharmaceutical compound TW200603806A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
TW200603806A true TW200603806A (en) 2006-02-01

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094120115A TW200603806A (en) 2004-06-30 2005-06-17 Pharmaceutical compound

Country Status (19)

Country Link
US (1) US20070249623A1 (cg-RX-API-DMAC7.html)
EP (1) EP1763521A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008505075A (cg-RX-API-DMAC7.html)
CN (1) CN1984903A (cg-RX-API-DMAC7.html)
AR (1) AR049659A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005267579A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512245A (cg-RX-API-DMAC7.html)
CA (1) CA2570634A1 (cg-RX-API-DMAC7.html)
EA (1) EA010307B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP067105A (cg-RX-API-DMAC7.html)
IL (1) IL179903A0 (cg-RX-API-DMAC7.html)
MA (1) MA28842B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06015112A (cg-RX-API-DMAC7.html)
NO (1) NO20070486L (cg-RX-API-DMAC7.html)
PE (1) PE20060480A1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002156A (cg-RX-API-DMAC7.html)
TW (1) TW200603806A (cg-RX-API-DMAC7.html)
WO (1) WO2006011955A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200610091B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
JP2002539194A (ja) * 1999-03-15 2002-11-19 ノボ ノルディスク アクティーゼルスカブ 新規の(2r,3r,4r)−3,4−ジヒドロキシ−2−ヒドロキシメチルピロリジンの塩
WO2000076971A2 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GEP20053712B (en) * 2001-05-14 2005-12-26 Pfizer Prod Inc Tartrate Salts of 5,8,14-Triazatetracyclo {10.3.1.0²,11.04,9}-Hexadeca-2(11),3,5,7,9-Pentaene and Pharmaceutical Compositions Thereof
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Also Published As

Publication number Publication date
ECSP067105A (es) 2007-01-26
MA28842B1 (fr) 2007-09-03
CA2570634A1 (en) 2006-02-02
AR049659A1 (es) 2006-08-23
SV2006002156A (es) 2006-02-15
EA200700186A1 (ru) 2007-06-29
MXPA06015112A (es) 2007-02-08
AU2005267579A1 (en) 2006-02-02
BRPI0512245A (pt) 2008-02-19
JP2008505075A (ja) 2008-02-21
IL179903A0 (en) 2007-05-15
EA010307B1 (ru) 2008-08-29
NO20070486L (no) 2007-01-25
ZA200610091B (en) 2008-02-27
PE20060480A1 (es) 2006-07-13
CN1984903A (zh) 2007-06-20
US20070249623A1 (en) 2007-10-25
WO2006011955A1 (en) 2006-02-02
EP1763521A1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
MX2007005408A (es) Compuestos de aminoquinazolinas.
MX2009004441A (es) Derivados de indazol utiles como inhibidores de las isoformas de higado.
NZ554374A (en) Diaminoalkane aspartic protease inhibitors
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
TW200800970A (en) Novel cycloalkane carboxamides
MY142441A (en) Azole derivatives as inhibitors of lipases and phospholipases
ATE275544T1 (de) Serinprotease-inhibitoren
GEP20125458B (en) Matrix metalloproteinase inhibitors
GEP20104878B (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
PL1628965T3 (pl) Związki hydroksyamidynowe i hydroksyguanidynowe jako inhibitory urokinazy
ZA200801332B (en) Pentacyclic kinase inhibitors
GEP20094801B (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
MY137876A (en) Pharmaceutical compound
TW200603806A (en) Pharmaceutical compound
MXPA06000652A (es) Sales alcalinas de inhibidores de bomba de protones.
PL373066A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
TW200630099A (en) Novel dicarboxamide derivatives
IL181183A (en) Use of an elastase inhibitor in the manufacture of a medicament for the treatment of leukemia
DOP2005000121A (es) Compuesto farmaceutico
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser
TH76317A (th) สารประกอบทางเภสัชกรรม
TH64469A (th) สารประกอบทางเภสัชกรรม
WO2003075926A8 (en) Use of proton pump inhibitors for the treatment of airway disorders
UA96610C2 (ru) Винилогические производные кислот как ингибиторы химазы
TW200605895A (en) Combination of a selective noradrenaline reuptake inhibitor and a PDEV inhibitor